Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening of Colorectal Cancer Using Improved SEPT9 (Septin 9) Gene Methylation Assay in Chinese Population

NCT02540850 is registered in ClinicalTrials.gov with BioChain (Beijing) Science and Technology, Inc. as lead sponsor.

NCT NCT02540850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02540850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening of Colorectal Cancer Using Improved SEPT9 (Septin 9) Gene Methylation Assay in Chinese Population
Lead sponsor
BioChain (Beijing) Science and Technology, Inc.
Phase
Observational
Overall status
Completed
Start date
February 28, 2014
Completion date
October 31, 2015
Enrollment
1,031 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adenomatous polyp of colon, colorectal cancer, other cancers, other disease/injury, polyps